17 results
20-F/A
2023 FY
BLRX
Bioline Rx Ltd
26 Mar 24
Annual report (foreign) (amended)
4:57pm
in inflation, along with the uncertainties surrounding any resurgence of COVID-19, geopolitical developments and global supply chain disruptions, have … to regulate pharmaceutical benefit managers (“PBMs”) and other members of the healthcare and pharmaceutical supply chain, an important decision that may
6-K
EX-99
BLRX
Bioline Rx Ltd
24 May 23
BioLineRx Reports First Quarter 2023 Financial Results and Recent Corporate
7:06am
-readiness activities. We recently completed hiring an experienced sales force, and have substantially advanced supply chain, market access and medical
424B5
5oj6 0gtpds4v
21 Jan 21
Prospectus supplement for primary offering
4:31pm
424B5
m3oewj9kouloe2n
19 Jan 21
Prospectus supplement for primary offering
5:00pm
F-3
quivv1m8
31 Dec 20
Shelf registration (foreign)
4:37pm
424B5
381zmu 86
31 Dec 20
Prospectus supplement for primary offering
4:31pm
6-K
EX-99
zybfy p4qp5z4hvo
23 Nov 20
BioLineRx Reports Third Quarter 2020 Financial Results
7:08am
424B5
qloxl0cixkx4sczbq
13 Nov 20
Prospectus supplement for primary offering
4:31pm
424B5
fbr19briv2imtxhnj m0
25 Sep 20
Prospectus supplement for primary offering
4:30pm
6-K
EX-99
156xrb7 h09
6 Aug 20
BioLineRx Reports Second Quarter 2020 Financial Results
7:47am
424B5
e2fhael9182y fv9oayc
3 Jun 20
Prospectus supplement for primary offering
8:33am
424B5
o8g8tr
28 May 20
Prospectus supplement for primary offering
12:00pm
6-K
EX-99
hpm15 kxu
20 May 20
BioLineRx Reports First Quarter 2020 Financial Results
7:00am
- Prev
- 1
- Next